Both Lovaza and Pegloticase offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Lovaza has fewer side effects and is less likely to interact with other medications, making it a safer choice for sensitive patients.

Both Lovaza and Pegloticase have a low risk of addiction when used correctly under medical supervision, with minimal potential for misuse.

Lovaza offers the convenience of a once-daily dose, simplifying treatment adherence for patients.

Both Lovaza and Pegloticase have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Both drugs offer advantages depending on treatment goals. Lovaza is great for fast relief, while Pegloticase is better for long-term management. The choice depends on the patient’s specific needs.